Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of allergic diseases and attention-deficit/hyperactivity (ADHD) disorder in children: a large-scale cohort study.

Allergologia et immunopathologia·2026
Same author

Key factors in the diagnosis of sesame allergy in children.

Allergy and asthma proceedings·2026
Same author

Predictors of Treatment Response to Omalizumab in Children with Chronic Spontaneous Urticaria: A Real World Study.

International archives of allergy and immunology·2026
Same author

PECU: A multicenter study on pediatric patients with cold-induced urticaria.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Efficacy and Adherence of Combined Fluticasone Propionate and Azelastine Nasal Spray Versus Fluticasone Propionate Alone in Pediatric Allergic Rhinitis.

Allergy, asthma & immunology research·2026
Same author

Factors affecting length of hospital stay in children with moderate to severe asthma exacerbations.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026

Related Experiment Video

Updated: Mar 22, 2026

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

84.4K

Is There Any Parameter Helpful for Predicting a Suitable Candidate for Mite Immunotherapy?

Sait Karaman1, Demet Can1, Semiha Bahçeci Erdem1

  • 1Dr Behcet Uz Children's Hospital, Department of Pediatric Allergy, Izmir, Turkey.

Iranian Journal of Allergy, Asthma, and Immunology
|April 20, 2016
PubMed
Summary

Serum total IgE levels can predict the clinical response to allergen immunotherapy (AIT) in children with house dust mite-induced asthma. Lower levels (≤ 339 kU/L) at diagnosis indicate a higher likelihood of successful AIT outcomes.

Keywords:
Allergen immunotherapyAsthmaChildrenImmunoglobulin EMite

More Related Videos

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.6K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K

Related Experiment Videos

Last Updated: Mar 22, 2026

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

84.4K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.6K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K

Area of Science:

  • Allergy and Immunology
  • Pediatric Asthma Research
  • Biomarker Discovery

Background:

  • Predicting clinical response to allergen immunotherapy (AIT) remains challenging.
  • Few reliable biomarkers exist for guiding AIT efficacy in children with asthma.
  • House dust mite allergy is a common trigger for pediatric asthma.

Purpose of the Study:

  • To identify predictive parameters for AIT clinical response in children with house dust mite-induced asthma.
  • To evaluate the utility of serum total IgE (tIgE) as a predictive biomarker for AIT success.
  • To compare clinical outcomes in children receiving AIT versus a control group.

Main Methods:

  • Evaluated 107 children with mild persistent asthma sensitized to mites.
  • Compared 47 patients undergoing 4-5 years of subcutaneous AIT with 60 controls.
  • Utilized multivariate logistic analysis to identify predictive parameters for remission.

Main Results:

  • Remission rates were significantly higher in the AIT group (74.5%) compared to controls (20%).
  • Serum total IgE (tIgE) at diagnosis was a significant predictor of clinical response to AIT (OR 131.64, p=0.032).
  • Serum tIgE levels ≤ 339 kU/L demonstrated 64.5% sensitivity and 88.9% specificity for predicting effective AIT.

Conclusions:

  • Serum total IgE (tIgE) level measurement can serve as a predictive test before initiating AIT.
  • tIgE levels ≤ 339 kU/L are associated with a favorable clinical response to AIT in mite-sensitized children.
  • This finding aids in optimizing AIT selection and management for pediatric asthma patients.